Cote dIvoire

Cote dIvoire

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
14.14 (13.59 - 14.68) 1990 Modelled IHME
13.92 (13.42 - 14.41) 1991 Modelled IHME
13.71 (13.25 - 14.16) 1992 Modelled IHME
13.49 (13.06 - 13.93) 1993 Modelled IHME
13.28 (12.87 - 13.72) 1994 Modelled IHME
13.07 (12.66 - 13.51) 1995 Modelled IHME
12.87 (12.49 - 13.28) 1996 Modelled IHME
12.68 (12.32 - 13.06) 1997 Modelled IHME
12.49 (12.13 - 12.83) 1998 Modelled IHME
12.28 (11.94 - 12.62) 1999 Modelled IHME
12.06 (11.72 - 12.40) 2000 Modelled IHME
11.82 (11.52 - 12.11) 2001 Modelled IHME
11.55 (11.27 - 11.83) 2002 Modelled IHME
11.26 (11.01 - 11.55) 2003 Modelled IHME
10.99 (10.74 - 11.26) 2004 Modelled IHME
10.72 (10.49 - 10.99) 2005 Modelled IHME
10.48 (10.26 - 10.72) 2006 Modelled IHME
10.24 (10.05 - 10.46) 2007 Modelled IHME
10.01 (9.83 - 10.21) 2008 Modelled IHME
9.78 (9.60 - 9.97) 2009 Modelled IHME
9.52 (9.35 - 9.71) 2010 Modelled IHME
9.25 (9.09 - 9.42) 2011 Modelled IHME
8.95 (8.80 - 9.11) 2012 Modelled IHME
8.65 (8.50 - 8.80) 2013 Modelled IHME
8.34 (8.20 - 8.49) 2014 Modelled IHME
8.05 (7.90 - 8.20) 2015 Modelled IHME
7.78 (7.66 - 7.90) 2016 Modelled IHME
7.49 (7.38 - 7.61) 2017 Modelled IHME
7.18 (7.08 - 7.29) 2018 Modelled IHME
6.85 (6.75 - 6.97) 2019 Modelled IHME
6.07 (4.59 - 7.88) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
10.9 (9.27 - 12.31) 1990 Modelled IHME
10.84 (9.30 - 12.13) 1991 Modelled IHME
10.68 (9.21 - 11.94) 1992 Modelled IHME
10.45 (9.10 - 11.71) 1993 Modelled IHME
10.16 (8.90 - 11.36) 1994 Modelled IHME
9.85 (8.67 - 11.03) 1995 Modelled IHME
9.41 (8.37 - 10.49) 1996 Modelled IHME
8.77 (7.86 - 9.72) 1997 Modelled IHME
8.02 (7.19 - 8.89) 1998 Modelled IHME
7.25 (6.50 - 8.04) 1999 Modelled IHME
6.53 (5.82 - 7.28) 2000 Modelled IHME
5.79 (5.21 - 6.43) 2001 Modelled IHME
4.97 (4.47 - 5.52) 2002 Modelled IHME
4.2 (3.76 - 4.68) 2003 Modelled IHME
3.6 (3.20 - 4.05) 2004 Modelled IHME
3.33 (2.95 - 3.76) 2005 Modelled IHME
3.28 (2.91 - 3.66) 2006 Modelled IHME
3.25 (2.89 - 3.61) 2007 Modelled IHME
3.23 (2.86 - 3.58) 2008 Modelled IHME
3.2 (2.83 - 3.55) 2009 Modelled IHME
3.15 (2.78 - 3.51) 2010 Modelled IHME
3.01 (2.66 - 3.31) 2011 Modelled IHME
2.74 (2.42 - 3.02) 2012 Modelled IHME
2.41 (2.12 - 2.67) 2013 Modelled IHME
2.07 (1.81 - 2.33) 2014 Modelled IHME
1.8 (1.57 - 2.05) 2015 Modelled IHME
1.59 (1.41 - 1.78) 2016 Modelled IHME
1.42 (1.26 - 1.59) 2017 Modelled IHME
1.31 (1.18 - 1.45) 2018 Modelled IHME
1.25 (1.08 - 1.40) 2019 Modelled IHME
3.04 (2.01 - 4.39) 2015 Modelled WHO
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
10.5 (4 - 21.50) 2014 Survey/reported Bouscaillou J et al, 2016
Technical notes

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
12.1 (9.11 - 16.10) 1990 Modelled IHME
12.3 (9.28 - 16.30) 1991 Modelled IHME
12.5 (9.31 - 16.50) 1992 Modelled IHME
12.7 (9.48 - 16.90) 1993 Modelled IHME
12.9 (9.56 - 17.20) 1994 Modelled IHME
13 (9.61 - 17.60) 1995 Modelled IHME
12.9 (9.42 - 17.50) 1996 Modelled IHME
12.5 (8.99 - 17) 1997 Modelled IHME
12.2 (8.70 - 16.70) 1998 Modelled IHME
11.8 (8.32 - 16.40) 1999 Modelled IHME
11.6 (8.21 - 16.40) 2000 Modelled IHME
11.5 (8.10 - 16.20) 2001 Modelled IHME
11.4 (7.92 - 15.90) 2002 Modelled IHME
11.3 (7.80 - 15.90) 2003 Modelled IHME
11.2 (7.71 - 15.70) 2004 Modelled IHME
11 (7.66 - 15.40) 2005 Modelled IHME
10.8 (7.44 - 15.10) 2006 Modelled IHME
10.5 (7.26 - 14.70) 2007 Modelled IHME
10.2 (6.99 - 14.30) 2008 Modelled IHME
9.97 (6.92 - 13.90) 2009 Modelled IHME
9.82 (6.73 - 13.80) 2010 Modelled IHME
9.54 (6.56 - 13.40) 2011 Modelled IHME
9.33 (6.50 - 13) 2012 Modelled IHME
9.23 (6.43 - 12.80) 2013 Modelled IHME
9.04 (6.28 - 12.50) 2014 Modelled IHME
8.79 (6.10 - 12.10) 2015 Modelled IHME
8.51 (5.93 - 11.80) 2016 Modelled IHME
8.47 (5.87 - 11.60) 2017 Modelled IHME
8.48 (5.84 - 11.80) 2018 Modelled IHME
8.29 (5.63 - 11.50) 2019 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,481.70 (1,114.35 - 1,973.23) 1990 Modelled IHME
1,563.49 (1,180.44 - 2,075.93) 1991 Modelled IHME
1,647.82 (1,229.42 - 2,174.85) 1992 Modelled IHME
1,744.50 (1,299.96 - 2,312.45) 1993 Modelled IHME
1,833.86 (1,358.53 - 2,447.99) 1994 Modelled IHME
1,918.08 (1,414.91 - 2,592.05) 1995 Modelled IHME
1,961.50 (1,433.73 - 2,661.13) 1996 Modelled IHME
1,964.81 (1,412.94 - 2,675.15) 1997 Modelled IHME
1,970.44 (1,409.16 - 2,701.04) 1998 Modelled IHME
1,969.84 (1,387.79 - 2,740.75) 1999 Modelled IHME
1,994.15 (1,406.83 - 2,809.02) 2000 Modelled IHME
2,029.17 (1,425.69 - 2,854.70) 2001 Modelled IHME
2,056.51 (1,430.60 - 2,863.90) 2002 Modelled IHME
2,089.75 (1,442.79 - 2,943.68) 2003 Modelled IHME
2,118.74 (1,461.14 - 2,971.78) 2004 Modelled IHME
2,134.66 (1,484.18 - 2,983.23) 2005 Modelled IHME
2,145.68 (1,476.16 - 2,997.88) 2006 Modelled IHME
2,131.29 (1,472.28 - 2,980.02) 2007 Modelled IHME
2,108.91 (1,449.98 - 2,956.20) 2008 Modelled IHME
2,113.15 (1,467.22 - 2,952.36) 2009 Modelled IHME
2,127.26 (1,457.55 - 2,989.95) 2010 Modelled IHME
2,109.29 (1,451.29 - 2,959.11) 2011 Modelled IHME
2,106.47 (1,469.08 - 2,928.14) 2012 Modelled IHME
2,128.50 (1,484.13 - 2,953.74) 2013 Modelled IHME
2,128.76 (1,480.02 - 2,949.49) 2014 Modelled IHME
2,114.47 (1,468.33 - 2,913.33) 2015 Modelled IHME
2,092.04 (1,457.80 - 2,890.95) 2016 Modelled IHME
2,124.53 (1,474.02 - 2,921.90) 2017 Modelled IHME
2,173.30 (1,495.59 - 3,023.26) 2018 Modelled IHME
2,169.12 (1,473.61 - 3,021.34) 2019 Modelled IHME
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
55 (47 - 64) 1990 Modelled IHME
56 (47 - 64) 1991 Modelled IHME
56 (47 - 64) 1992 Modelled IHME
56 (47 - 65) 1993 Modelled IHME
56 (48 - 65) 1994 Modelled IHME
56 (47 - 65) 1995 Modelled IHME
56 (47 - 65) 1996 Modelled IHME
56 (47 - 64) 1997 Modelled IHME
55 (46 - 64) 1998 Modelled IHME
55 (46 - 64) 1999 Modelled IHME
54 (45 - 63) 2000 Modelled IHME
54 (45 - 63) 2001 Modelled IHME
54 (45 - 62) 2002 Modelled IHME
54 (45 - 62) 2003 Modelled IHME
54 (45 - 62) 2004 Modelled IHME
53 (45 - 62) 2005 Modelled IHME
53 (45 - 61) 2006 Modelled IHME
53 (45 - 61) 2007 Modelled IHME
52 (44 - 61) 2008 Modelled IHME
52 (44 - 61) 2009 Modelled IHME
52 (44 - 60) 2010 Modelled IHME
52 (44 - 60) 2011 Modelled IHME
51 (44 - 60) 2012 Modelled IHME
51 (43 - 60) 2013 Modelled IHME
51 (43 - 60) 2014 Modelled IHME
51 (42 - 59) 2015 Modelled IHME
51 (42 - 59) 2016 Modelled IHME
51 (42 - 59) 2017 Modelled IHME
51 (43 - 59) 2018 Modelled IHME
50 (42 - 59) 2019 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
82 2018 Survey/reported WHO/UNICEF
83 2017 Survey/reported WHO/UNICEF
85 2016 Survey/reported WHO/UNICEF
77 2015 Survey/reported WHO/UNICEF
73 2014 Survey/reported WHO/UNICEF
75 2013 Survey/reported WHO/UNICEF
82 2012 Survey/reported WHO/UNICEF
62 2011 Survey/reported WHO/UNICEF
85 2010 Survey/reported WHO/UNICEF
81 2009 Survey/reported WHO/UNICEF
74 2008 Survey/reported WHO/UNICEF
76 2007 Survey/reported WHO/UNICEF
77 2006 Survey/reported WHO/UNICEF
76 2005 Survey/reported WHO/UNICEF
67 2004 Survey/reported WHO/UNICEF
63 2003 Survey/reported WHO/UNICEF
48 2002 Survey/reported WHO/UNICEF
10 2001 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.81 (2.24 - 3.52) 1990 Modelled IHME
2.79 (2.24 - 3.51) 1991 Modelled IHME
2.77 (2.22 - 3.51) 1992 Modelled IHME
2.76 (2.21 - 3.50) 1993 Modelled IHME
2.74 (2.19 - 3.49) 1994 Modelled IHME
2.73 (2.18 - 3.48) 1995 Modelled IHME
2.73 (2.18 - 3.47) 1996 Modelled IHME
2.72 (2.18 - 3.45) 1997 Modelled IHME
2.72 (2.17 - 3.43) 1998 Modelled IHME
2.71 (2.16 - 3.41) 1999 Modelled IHME
2.71 (2.16 - 3.39) 2000 Modelled IHME
2.7 (2.15 - 3.38) 2001 Modelled IHME
2.69 (2.15 - 3.39) 2002 Modelled IHME
2.68 (2.15 - 3.38) 2003 Modelled IHME
2.67 (2.14 - 3.36) 2004 Modelled IHME
2.66 (2.12 - 3.35) 2005 Modelled IHME
2.65 (2.12 - 3.33) 2006 Modelled IHME
2.64 (2.11 - 3.32) 2007 Modelled IHME
2.62 (2.11 - 3.29) 2008 Modelled IHME
2.61 (2.08 - 3.26) 2009 Modelled IHME
2.59 (2.07 - 3.23) 2010 Modelled IHME
2.56 (2.06 - 3.19) 2011 Modelled IHME
2.53 (2.03 - 3.17) 2012 Modelled IHME
2.5 (2.01 - 3.13) 2013 Modelled IHME
2.46 (1.98 - 3.10) 2014 Modelled IHME
2.44 (1.95 - 3.07) 2015 Modelled IHME
2.42 (1.93 - 3.05) 2016 Modelled IHME
2.41 (1.92 - 3.03) 2017 Modelled IHME
2.4 (1.92 - 3.01) 2018 Modelled IHME
2.4 (1.92 - 2.99) 2019 Modelled IHME
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
3.3 (0.80 - 12.80) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
1.8 (0 - 9.40) 2014 Survey/reported Bouscaillou J et al, 2016
Technical notes

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.41 (0.98 - 1.94) 1990 Modelled IHME
1.42 (0.98 - 1.98) 1991 Modelled IHME
1.43 (0.97 - 1.99) 1992 Modelled IHME
1.45 (0.99 - 2.03) 1993 Modelled IHME
1.47 (0.99 - 2.08) 1994 Modelled IHME
1.49 (1 - 2.13) 1995 Modelled IHME
1.49 (0.99 - 2.15) 1996 Modelled IHME
1.49 (0.99 - 2.14) 1997 Modelled IHME
1.48 (0.99 - 2.12) 1998 Modelled IHME
1.46 (0.97 - 2.09) 1999 Modelled IHME
1.45 (0.96 - 2.11) 2000 Modelled IHME
1.43 (0.95 - 2.10) 2001 Modelled IHME
1.41 (0.94 - 2.07) 2002 Modelled IHME
1.39 (0.91 - 2.06) 2003 Modelled IHME
1.37 (0.90 - 2.04) 2004 Modelled IHME
1.35 (0.87 - 2.01) 2005 Modelled IHME
1.34 (0.86 - 2) 2006 Modelled IHME
1.34 (0.86 - 2.02) 2007 Modelled IHME
1.34 (0.87 - 2.02) 2008 Modelled IHME
1.37 (0.89 - 2.04) 2009 Modelled IHME
1.38 (0.91 - 2.07) 2010 Modelled IHME
1.37 (0.89 - 2.03) 2011 Modelled IHME
1.35 (0.89 - 2) 2012 Modelled IHME
1.35 (0.88 - 1.99) 2013 Modelled IHME
1.33 (0.87 - 1.96) 2014 Modelled IHME
1.3 (0.85 - 1.92) 2015 Modelled IHME
1.27 (0.82 - 1.90) 2016 Modelled IHME
1.26 (0.83 - 1.89) 2017 Modelled IHME
1.26 (0.82 - 1.89) 2018 Modelled IHME
1.24 (0.80 - 1.85) 2019 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
172.89 (119.92 - 237.01) 1990 Modelled IHME
180.4 (124.39 - 251.19) 1991 Modelled IHME
188.65 (128.26 - 262.61) 1992 Modelled IHME
198.92 (135.57 - 277.95) 1993 Modelled IHME
209.05 (140.52 - 295.05) 1994 Modelled IHME
219.32 (146.71 - 313.15) 1995 Modelled IHME
227.43 (151.05 - 326.89) 1996 Modelled IHME
233.66 (154.90 - 335.83) 1997 Modelled IHME
240.07 (160.72 - 342.97) 1998 Modelled IHME
244.07 (162.12 - 349.43) 1999 Modelled IHME
248.8 (163.97 - 361.99) 2000 Modelled IHME
252.02 (166.93 - 369.75) 2001 Modelled IHME
254.28 (169.39 - 373.08) 2002 Modelled IHME
256.82 (168.70 - 381.01) 2003 Modelled IHME
259.16 (169.85 - 386.12) 2004 Modelled IHME
261.14 (168.47 - 389.80) 2005 Modelled IHME
265.77 (170.10 - 396.52) 2006 Modelled IHME
271.26 (174.86 - 409.53) 2007 Modelled IHME
278.69 (180.65 - 419.44) 2008 Modelled IHME
289.33 (189.19 - 432.24) 2009 Modelled IHME
299.26 (196.50 - 447.37) 2010 Modelled IHME
302.21 (196.55 - 448.52) 2011 Modelled IHME
305.74 (199.92 - 451.72) 2012 Modelled IHME
311.9 (202.47 - 458.24) 2013 Modelled IHME
313.78 (203.84 - 460.74) 2014 Modelled IHME
313.48 (204.59 - 461.20) 2015 Modelled IHME
311.22 (201.90 - 465.68) 2016 Modelled IHME
316.61 (207.78 - 473.75) 2017 Modelled IHME
323.91 (211.27 - 483.59) 2018 Modelled IHME
323.44 (209.98 - 485.10) 2019 Modelled IHME
1,313 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
13 (9 - 18) 1990 Modelled IHME
13 (8 - 18) 1991 Modelled IHME
13 (8 - 17) 1992 Modelled IHME
12 (8 - 17) 1993 Modelled IHME
12 (8 - 17) 1994 Modelled IHME
12 (8 - 17) 1995 Modelled IHME
12 (8 - 17) 1996 Modelled IHME
12 (8 - 17) 1997 Modelled IHME
12 (8 - 17) 1998 Modelled IHME
13 (8 - 18) 1999 Modelled IHME
13 (8 - 18) 2000 Modelled IHME
13 (9 - 18) 2001 Modelled IHME
13 (9 - 18) 2002 Modelled IHME
13 (9 - 18) 2003 Modelled IHME
13 (9 - 18) 2004 Modelled IHME
14 (9 - 19) 2005 Modelled IHME
14 (9 - 19) 2006 Modelled IHME
14 (9 - 19) 2007 Modelled IHME
14 (10 - 19) 2008 Modelled IHME
14 (10 - 19) 2009 Modelled IHME
14 (10 - 19) 2010 Modelled IHME
14 (10 - 19) 2011 Modelled IHME
15 (10 - 19) 2012 Modelled IHME
15 (10 - 20) 2013 Modelled IHME
15 (10 - 20) 2014 Modelled IHME
15 (10 - 20) 2015 Modelled IHME
15 (10 - 20) 2016 Modelled IHME
15 (10 - 20) 2017 Modelled IHME
15 (10 - 20) 2018 Modelled IHME
15 (10 - 20) 2019 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
2,169.12
2019
(1,473.61 - 3,021.34)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
323.44
2019
(209.98 - 485.10)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines